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Bone morphogenetic protein 1 (BMP1) is an astacin metalloprotease with important cellular functions and diverse substrates, including
extracellular-matrix proteins and antagonists of some TGFb superfamily members. Combining whole-exome sequencing and filtering
for homozygous stretches of identified variants, we found a homozygous causative BMP1 mutation, c.34G>C, in a consanguineous
family affected by increased bone mineral density and multiple recurrent fractures. The mutation is located within the BMP1 signal
peptide and leads to impaired secretion and an alteration in posttranslationalmodification.We also characterize a zebrafish bonemutant
harboring lesions in bmp1a, demonstrating conservation of BMP1 function in osteogenesis across species. Genetic, biochemical, and
histological analyses of this mutant and a comparison to a second, similar locus reveal that Bmp1a is critically required for mature-
collagen generation, downstream of osteoblast maturation, in bone.We thus define themolecular and cellular bases of BMP1-dependent
osteogenesis and show the importance of this protein for bone formation and stability.Introduction
Osteogenesis imperfecta (OI), also known as ‘‘brittle-bone
disease’’ is a rare genetic collagenopathy primarily charac-
terized by dramatically increased bone fragility causing
susceptibility to numerous fractures.1,2 Individuals often
show distinctive features including reduced bone mass,
short stature, blue sclerae, and/or dentinogenesis imper-
fecta. The severity of this disorder varies from profound
forms with intrauterine fractures and perinatal lethality to
milder phenotypic expression such as rare fractures or
even no fractures.3,4 Most OI cases are inherited in an auto-
somal-dominant manner and are caused by mutations in
COL1A1 (MIM 120150) and COL1A2 (MIM 120160);5,6
these two genes encode for the two a chains of collagen
type I, the predominant protein component of the bone
matrix. For a minority of OI individuals, an autosomal-
recessive inheritance is described as including underlying
mutations in CRTAP7 (MIM 605497), LEPRE18 (MIM
610339), SERPINH19 (MIM 600943), PPIB10 (MIM
123841), SP711 (MIM 606633), SERPINF112 (MIM 172860),
and FKBP1013 (MIM 607063). Mutations in COL1A1 or
COL1A2 result in primary structural or quantitative defects
of collagen I molecules, whereas genetic mutations causa-
tive for recessive forms mainly lead to defects in collagen I
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The Amwith reduced bone mineralization and bone fragility not
only in individuals suffering from congenital OI but also
in elderly individuals who have developed osteoporosis.14
Type I collagen belongs to the fibril-forming collagens
and is composed of a triple helix consisting of two a1(I)
chains and one a2(I) chain. The a chains are synthesized
at the rough endoplasmic reticulum (ER). They are highly
post-translationally modified in the ER lumen and are
subsequently assembled to a triple helix. This premature
collagen helix, which contains globular appendages at
the amino (N-) and carboxyl (C-) ends, is then transported
through the trans-golgi network to the extracellular matrix
(ECM), where N- and C-proteinases catalyze proteolytic
cleavage of these propeptides. After this final processing
step, the released mature collagen I triple-helical monomer
can be assembled into highly ordered collagen fibrils.15,16
Bonemorphogenetic protein 1 (BMP1) is an astacin met-
alloprotease,17,18 the physiological function of which has
been of considerable interest for some time. This protein
has been suggested to play essential roles in osteogenesis
and ECM formation; it has also been described as exerting
influence over dorsal-ventral patterning through the indi-
rect activation of some TGFb-like proteins.19–21 Of partic-
ular interest has been the role of BMP1 in proteolytic
removal of the C-propeptides from procollagen precursors
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essential for the self-assembly of mature collagen mono-
mers into fibrils.22 The precise functional requirement of
BMP1 in vivo is unclear. To date, Bmp1 loss of function
has only been analyzed in a knock-out mouse, in which
it was found to be lethal around birth and for which no
detailed analysis of osteogenesis was presented.23 Thus,
the role of BMP1 in bone formation and organogenesis
remains obscure.
Here, we describe two siblings with a high-bone-density
form of OI, identify a causative mutation in BMP1, and
provide detailed analysis of the effect of the mutation on
BMP1modification and secretion. We show that the hypo-
functional nature of the mutation is demonstrated in vivo
by using two assays that test substrate cleavage in zebra-
fish. We further describe a zebrafish Bmp1a mutant with
skeletal defects comparable to those seen in individuals
with OI, demonstrating conservation of important BMP1
function in osteogenesis across species. Our analysis of
these mutants has demonstrated that loss of Bmp1a affects
neither osteoblast formation nor activity but rather the
ability to generate mature collagen fibrils. This finding
therefore indicates that BMP1 is very much required in
the process of bone formation.Material and Methods
Whole-Exome Sequencing
Genomic DNA was enriched from exonic and adjacent splice-site
sequences by the use of the Agilent SureSelect Human Exome
Kit and run on the Illumina Genome Analyzer IIX Sequencer.
Further data analysis was performed with an in-house bioinfor-
matics pipeline in combination with SAMTOOLS v.0.1.7 for SNP
and indel detection. In-house-developed scripts were applied for
the detection of protein changes, splice-site affections, and over-
laps with known variations (Ensembl build 61 and 1,000 Genomes
Project release 2010_3).
Mutation Screening
The identified mutation was resequenced in an independent
experiment, tested for cosegregation with the phenotype within
the family, and then screened in 300 healthy control individuals
from Turkey by PCR and restriction digestion (AvaI; Fermentas,
St. Leon-Rot, Germany). All subjects or their legal representatives
gave written informed consent for the study. The study was per-
formed in accordance with the Declaration of Helsinki protocols
and was approved by the local institutional review boards.
Generation of BMP1 Constructs
TheBMP1-FLAGpcDNA3.1 construct contained full-lengthhuman
cDNA of BMP1 (RefSeq accession number NM_001199.3) and was
fused to a C-terminal FLAG tag; it was provided by the group of
Karl E. Kadler (University of Manchester, UK) and was used for
BMP1 expression studies. The identified substitution, p.Gly12Arg,
was introduced by site-directed PCR mutagenesis with the use of
a primer containing the specific nucleotide substitution.
Cell Culture and Transient Transfection
Human embryonic kidney (HEK) 293T cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) containing 10%662 The American Journal of Human Genetics 90, 661–674, April 6, 2fetal bovine serum (FBS, GIBCO) and antibiotics. Cells were
transiently transfected with Lipofectamine 2000 (Invitrogen,
Karlsruhe, Germany) and vectors containing wild-type (WT) and
mutant variants of BMP1 cDNA. Transfections were performed
according to the manufacturer’s instructions.
Secretion Assay and Immunoblot Analysis
30 hr after transient transfection, cells and untransfected control
cells were maintained in serum-free medium for 18 hr at 37C.
After starvation, supernatant-containing secreted proteins were
precipitated by trichloroacetic acid, and cells were lysed with ice-
cold lysis buffer. The total protein concentration of the extracts
was determined by the BCA (bicinchoninic acid) Protein Assay
Kit (Pierce Protein Research Products, Thermo Fischer Scientific,
Rockford, IL, USA), and proteins were separated by gradient
(4%–12%) SDS-PAGE (Invitrogen) under reducing conditions
and transferred to a nitrocellulose membrane by immunoblotting.
Immunoblots were blocked in 5% milk powder in TBS containing
0.1% Tween20, and they were probed with Flag antibody (Agilent
Technologies, Waldbronn, Germany). Equal protein amounts
were confirmed by b-actin detection in whole-cell lysates or by
Coomassie staining of a ~65 kDa protein in supernatant of
serum-free medium. A peroxidase-conjugated secondary antibody
(goat anti-mouse) was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), and blots were developed with an
enhanced chemiluminescence system, ECL Plus (Amersham,
UK); exposure on autoradiographic film (GE Healthcare, Mu¨n-
chen, Germany) followed.
Zebrafish Studies
Radioimmunoprecipitation (RIPA) buffer (50 mM Tris-HCl, pH
7.6, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, and
1% NP-40) was used for the extraction of total protein from zebra-
fish larvae (6 days old) or fins (4 months old), and the protein was
measured with a standard Bradford assay. Proteins (20 mg) were
separated on a 6% denaturing polyacrylamide gel, transferred to
a nitrocellulose membrane, and probed with a rabbit polyclonal
antibody raised against a peptide of zebrafish Collagen1a1a.
Goat anti-rabbit antibody conjugated with horseradish peroxidase
(HRP) was employed as a secondary antibody, and the bands were
visualized with chemiluminescence detection (Millipore, Billerica,
MA, USA). For the loading control, blots were stripped and then
reprobed with a rabbit anti-b-actin antibody (Cell Signaling
Technology, Danvers, MA, USA).
N-glycosidase Assay
For the N-glycosylation studies, 20 mg of whole-cell lysates of
transiently transfected and untransfected HEK 293T cells were
either treated with N-glycosidase F (PNGaseF) (New England
BioLabs, Frankfurt, Germany) or left untreated. The enzyme reac-
tion was performed according to the manufacturer’s instructions.
Proteins were subjected to SDS-PAGE and analyzed by anti-Flag
immunoblotting. Equal protein amounts were confirmed by
b-actin detection.
Fish Lines and Mapping
Embryos were obtained by natural crosses and were staged as per
Parichy et al.24 Themicrowaved (med tt281), dino (chd tt250), and frilly
fins (frf tm317a, frf tf5, frf tp34, and frf ty68) alleles that we used have
been described previously25 and were isolated in an N-ethyl-N-
nitrosourea (ENU) screen in Freiburg (frf fr24). frf tm317 was used012
for all analyses. The Tg(sp7:mCherry) transgenic line has been re-
ported previously.26 We performed genetic mapping by crossing
frfþ/ and medþ/ fish to the WIK strain and by subjecting the
F2 progeny to simple-sequence-length polymorphism (SSLP)
meiotic mapping as outlined by Geisler.27 Heat shocks were per-
formed at 37C for 1 hr at 30 and 56 hr postfertilization (hpf).
Microscopy
Fluorescent images were taken on an Olympus Fluoview confocal
microscope, whereas brightfield and Nomarski micrographs were
taken on a Zeiss Axioimager or a Leica MZ16FA. For live imaging,
larvae were anesthetized in Tricaine and mounted in 3% methyl
cellulose or 1% low-melting-point agarose. All whole-mount stain-
ings using alizarin red, in situ hybridization, or immunodetection
were cleared in glycerol prior to mounting. Stained ultrathin
sections of the fins were employed for transmission electron
microscopy (TEM) on a Jeol JEM-1010 electron microscope.
RNA and DNA Isolation, cDNA Synthesis,
and Sequencing
Trizol (Invitrogen, CA, USA) was used for the isolation of RNA
from WT or mutant larvae, and SuperscriptIII Reverse Transcrip-
tase (Invitrogen, CA, USA) was used for the generation of cDNA
by reverse transcription. RT-PCR was used for the amplification
of bmp1a cDNA from all frilly finsmutated alleles and correspond-
ing siblings. Similarly, col1a1a cDNA was amplified from the
microwaved mutant allele and siblings. Resulting PCR fragments
were purified and sequenced directly. To identify mutations at
the genomic level, we extracted larval genomic DNA and directly
sequenced the region of interest from amplified PCR products.
DNA Construct Generation
Gateway cloning technology and entry constructs from the
Tol2Kit28 were used for the generation of zebrafish and Myc-
tagged human Bmp1 heat-shock constructs. Bmp1 coding regions
were cloned into a middle entry vector via standard cloning
methods or through a BP Gateway reaction.
DNA and RNA Injections
DNA and RNAs were diluted in Danieau buffer and Phenol
red before being injected into 1-cell embryos by a Pico-Injector
(Harvard Apparatus, MA, USA). Sense RNAs for overexpression
or rescue were transcribed from cDNAs and cloned into pCS2þ.
Plasmids were linearized with NotI, and capped mRNA was
synthesized with mMessage mMachine SP6 kit (Ambion, Applied
Biosystems, Austin, TX, USA). Full-length cDNA for BMP1 was
amplified from a HeLa-cell cDNA library and cloned into pCS2þ.
A primer harboring the p.Gly12Arg signal-peptide substitution
was used for the generation of the mutant BMP1 cDNA version
by PCR. chordin RNA was transcribed as previously reported.29
chordin and BMP1 RNA were injected at a concentration of 60
and 450 pg, respectively. To generate adult dino mutants, we
rescued early patterning defects by injecting 30 pg of chordin
RNA. Tol2 RNA was generated as published.30
In Situ Hybridization
Single- and double-stranded-RNA in situ hybridizations were
performed and developed with either chromogenic substrate31
or fluorescent tyramide signal amplification.32 Probes for sp7,
osteopontin, and collagen10a1 were synthesized as described.33
The bmp1a probe was generated with EcoRI by linearizing cloneThe AmIMAGp998H0417161 from ImaGenes (Berlin, Germany) and was
transcribed with T7 Polymerase. In situ hybridization of 8 dpf
(days postfertilization) larvae required extended 40min proteinase
K (15 mg/ml) digestions at room temperature, 48 hr hybridization
in the antisense probe, and 2 days of signal development at room
temperature.
Skeletal and Matrix Staining
Bones of larvae and adult fish were stained with alizarin red alone
or in combinationwith the cartilage stain, alcian blue, as described
by Walker et al.34 and Spoorendonk et al.26 For microscopic anal-
ysis of fibrillar collagen organization, fins and larvae were fixed in
4% paraformaldehyde and embedded in 1% agarose for cryosec-
tioning. Sections were stained with picrosirius red as previously
described35 and were visualized by birefringence under polariza-
tion filters.
Antibody Staining
Myc-tagged BMP1 proteins were detected by whole-mount
immunofluorescent staining with the 9E10 monoclonal antibody
(Santa Cruz, CA, USA). 3 dpf embryos were fixed in 4% paraformal-
dehyde overnight at 4C and were then washed with 0.1% PBS
Triton X-100. Embryos were permeabilized by incubation in
100% acetone for 7 min at 20C, were rewashed, and were
blocked overnight in PBS/Triton with 0.5% goat serum and 0.1%
dimethyl sulfoxide. After extensive washing, the embryos
were incubated with Alexa488-conjugated secondary antibodies
(Invitrogen) diluted in blocking solution. Finally, embryos were
rewashed before they were cleared in glycerol. Osteoblasts of
the adult fins were stained with the zns5 monoclonal antibody
(obtained from the Zebrafish International Resource Center
[Eugene, OR, USA]) either in the wholemount or after cryosection-
ing. Theywere then counterstainedwith either alizarin red (for the
whole mounts) or DAPI (for the cryosections) as per previous
methods.36
Retinoic-Acid Treatment
We purchased all-trans retinoic acid (RA) from Sigma (MI, USA),
and we made a 1 mM stock solution by dissolving it in ethanol.
Larvae were treated with 1 mM RA diluted in egg water at 4 dpf.
The controls were exposed to an equivalent amount of just the
carrier (ethanol). Fresh solution was added every other day until
the fish were fixed at 11 dpf for alizarin-red processing.
MicroCT Scanning of Adult Fish
Adult fish were euthanized in Tricaine and scanned immediately
at 40 kV, 130 mAwith a Siemens Inveon PET-CT (positron emission
tomography-computed tomography) scanner. The images were
reconstructed and analyzed with Inveon Acquisition Workplace
1.4 and Inveon Research Workplace 3.0, respectively. Bone
mineral density was calculated with the density-phantoms stan-
dards supplied by the company.Results
A Homozygous BMP1 Mutation Causes High Bone
Mineral Density and Multiple Fractures
Weusedwhole-exome sequencing to identify the causative
mutation underlying an autosomal-recessive form of bone
fragility in a consanguineous family from Turkey. Botherican Journal of Human Genetics 90, 661–674, April 6, 2012 663
Figure 1. Two Siblings with Autosomal-
Recessive Bone Fragility and High-Bone-
Mass Phenotype
(A and B) Clinical data of both individuals
are shown. Above, diagrams illustrate Z
scores of bone-mineral-density measure-
ments of the head and vertebrae L2–L4,
respectively, indicating highly increased
levels of bone mineral density. X-rays show
fractured and bent forearms (below) and
spinal columns (right) of individuals. High-
radiation X-rays of the forearm and spinal
column of individual 1 indicate an intense
bone density. Vertebrae of individual 2 are
flattened and irregularly formed (B).affected individuals (Figures 1A and 1B and Table 1) pre-
sented with multiple fractures after minimal trauma
occurred in their second year of life. Interestingly, despite
recurrent fractures, bone-density measurements showed
values high above the normal range in both individuals
(Figures 1A and 1B). The male index individual had >15
fractures before bisphosphonate treatment was initiated;
this treatment was administered on the basis of the
hypothesis that the individuals had an OI-like disease
with a high rate of fractures, including vertebral fractures,
as a result of impaired bone material with high production
rates and high bone turnover. Osteoclastic activities were
elevated and measured by deoxypyridinoline excretion.
These clinical and biochemical findings were not typical
of a classical form of osteopetrosis. After treatment began,
we observed increased bone mass, reduced fractures, and
improved vertebral structures. When the bisphosphonate
treatment was completed, fracture rates again began to
increase. Increased bone mass and a reduced fracture rate
were also observed in his affected sister while she was664 The American Journal of Human Genetics 90, 661–674, April 6, 2012undergoing bisphosphonate therapy.
High Z scores were seen before and
during therapy.
The exome of the proband was
enriched by the Agilent SureSelect
Human Exome kit and was run on
an Illumina Genome Analyzer IIX.
Over 90% of the exonic sequences
had coverage of at least 203 (Fig-
ure 2A), and the mean coverage was
723. We took advantage of the
parental consanguinity (Figure 2B),
and we used linkage analysis to deter-
mine larger stretches of homozygosity
in the exome by using identified
variants throughout the exome as
haplotype blocks. In addition to
filtering variants for their location
within the identified stretches of
homozygosity, we considered those
variants that were not annotated in
dbSNP132 or the 1,000 GenomesDatabase to be possibly causative; this reduced the number
of putative variants to three (Table S1, available online).
The relevant alteration was the homozygous c.34G>C
substitution located in the excellent functional candidate
gene, BMP1. Sanger sequencing confirmed that both
affected individuals were homozygous for the c.34G>C
mutation, whereas both parents were heterozygous. In
addition, it was detected neither in 300 healthy Turkish
control individuals nor in over 2,400 exomes covering
the c.34G>C position (Exome Variant Server, National
Heart, Lung, and Blood Institute Exome Sequencing
Project [ESP], Seattle, WA; Figure 2C).
Functional Effects of the p.Gly12Arg Substitution
in BMP1
The mutation is predicted to substitute arginine for a
conserved glycine residue (p.Gly12Arg) within the signal
peptide of BMP1 (Figure 2D); this signal peptide is essential
for the protein’s localization to the ER, correct posttransla-
tional glycosylation, and secretion.37 Indeed, we found
Table 1. Clinical Features of Both Individuals
Findings Individual IV:1 Individual IV:2
Age at first visit (years) 5.0 1.9
Age at last visit (years) 11.4 7.5
Age at start of bisphosphonate treatment (years) 5.4 2.8
Age at end of bisphosphonate treatment (years) 10.4 7.5
Birth length and birth weight normal normal
Confirmed prenatal fractures none none
Age at first fracture (months) 23 14
Color of sclera white white
Dentinogenesis imperfecta no no
Hypermobility of joints no no
Cardial impairments none none
Hearing impairment no no
Old fractures of extremitiesa yes yes
Vertebral fracturesa yes yes
Bowing of upper extremitiesa no no
Bowing of lower extremitiesa antecurvation of both tibiae no
Shortening of upper extremitiesa no no
Shortening of lower extremitiesa no no
Weight at first visit in kg/BMI (SD) 23.6 (þ1.8) 10.5 (0.4)
Weight at end of bisphosphonate treatment in kg/BMI (SD) 44.0 (þ1.7) 22.0 (þ0.8)
Height at first visit in cm (SD) 112.0 (þ0.1) 82.3 (0.7)
Height at end of bisphosphonate treatment in cm (SD) 139.0 (0.6) 112.2 (2.6)
Retarded gross motor functions no no
Mobility at first visit (BAMF score) 8 7
Mobility at last visit (BAMF score) 9 9
Intelligence normal normal
Calcium levela (mmol/l) [range] 2.43 [2.20–2.65] 2.28 [2.20–2.65]
Alkaline phosphatase at first visit (U/l) [range] 133 [<269] 107 [<281]
Alkaline phosphatase at last visit (U/l) [range] 116 [<300] 114 [<300]
Procollagen-1-C-peptidea (marker for osteoblastic activity) (mg/l) [range] 170 [193–716] 141 [225–676]
Deoxypyridinoline/creatinine (marker for osteoclastic activity) at first visit (nM/mM)
[mean 5 SD]
58.66 [16.5 5 5.0] 63.9 [19.5 5 7.2]
Deoxypyridinoline/creatinine (marker for osteoclastic activity) at end of bisphosphonate
treatment (nM/mM) [mean 5 SD]
17.6 [14.2 5 5.3] 29.9 [19.5 5 7.2]
The following abbreviations are used: SD, standard deviation; BMI, body mass index; and BAMF, brief assessment of motor function.
aAt first presentation.that in contrast to the Flag-tagged WT BMP1 that is
transiently expressed in HEK 293T cells, the p.Gly12Arg
signal-peptide variant BMP1 showed a drastically reduced
secretion capacity (Figure 3A). Moreover, we detected a
predominant additional lower-molecular-weight band for
mutant BMP1 in immunoblots from cell lysates. Results
from N-glycosidase treatment of WT and mutant-BMP1-
transfected HEK 293T cells indicated that the lower bandThe Amin untreated lysates represented a nonglycosylated form
of BMP1 (Figure 3B). Interestingly, deficits in BMP1 glyco-
sylation can also negatively impact secretion.37 These data
thus indicate that p.Gly12Arg BMP1 is inefficiently
secreted and has diminished posttranslational glycosyla-
tion, which might contribute to its impaired secretion.
To assess whether the amino acid substitution in the signal
peptide causes a reduction in extracellular proteolyticerican Journal of Human Genetics 90, 661–674, April 6, 2012 665
Figure 2. Whole-Exome Sequencing and Filtering Identify Mutation in BMP1
(A) Statistical overview of target-base coverage during sequencing process. Over 90% of identified variations were covered more
than 203.
(B) Pedigree structure of the consanguineous Turkish family.
(C) Sequence chromatograms of the identified c.34G>C BMP1mutation predicted to substitute the glycine at position 12 with arginine.
The c.34G>Cmutation was found to be heterozygous (middle panel) in both parents and homozygous in both individuals (right panel).
(D) Schematic view of BMP1 domain structure. The locations of identified mutations in humans (above) and zebrafish (below) are
shown. Note that the frf tf5 mutation generates multiple splice isoforms. The following abbreviation is used: SP, signal peptide.activity, we analyzed dorsal-ventral patterning of the ze-
brafish embryo—a process which is extremely sensitive
to levels of the Bmp1 target, Chordin—as an in vivo assay
for BMP1 function. Injection of WT BMP1 RNA evoked
a mild ventralization of embryos, whereas the mutant
RNA had quantitatively reduced activity (Figures 3C–3E
and 3I). Exogenous chordin RNA dorsalizes embryos
(Figures 3F and 3I), an effect efficiently reversed by WT
BMP1 RNA but not by the mutant RNA (Figures 3G–3I).
These data demonstrate that the p.Gly12Arg substitution
compromises BMP1 activity in vivo and imply that the
human enzyme can cleave the targets of its zebrafish
counterpart.
Phenotypic Characterization of the Zebrafish frilly fins
Mutant
We analyzed the zebrafish frilly fins (frf/) mutant, which
was initially described as causing a phenotype25 character-
ized by a ruffled larval fin (Figures 4A and 4B) as well as a
shortened body axis andmalformed craniofacial structures
and fin shape (Figures 4C and 4D). We observed a striking666 The American Journal of Human Genetics 90, 661–674, April 6, 2reduction in ossification of vertebrae from 6 dpf to 11 dpf
(Figures 4E and 4F; data not shown). The osteopenia
persisted in such a manner that at 15 dpf, the anterior
vertebrae had partially ossified but were misshapen
(Figures 4I and 4J). The fact that overall length and
growth of mutant larvae were not reduced at this stage
argues against a general developmental delay (data not
shown). By 25 dpf, all frf mutant vertebrae appeared to
have ossified (Figures S1E and S1F), but fusions could be
seen between some vertebrae (Figures S1G and S1H). Fins
appeared hypomorphic at all stages, and delayed develop-
ment of bony rays (lepidotrichia) appeared at 25 dpf
(Figures S1E and S1F). Adult fins had reduced numbers of
lepidotrichia, which appeared wavy, underwent limited
bifurcation, and were often fused to adjacent rays (Figures
4K and 4L). The presence of calluses is suggestive of spon-
taneous fracturing during fin outgrowth (Figure 4L). We
generated maternal-zygotic mutant embryos from five
alleles; the fact that none were dorsalized indicates that
Bmp1a is dispensable for dorsal-ventral patterning (data
not shown).012
Figure 3. A Signal-Peptide Substitution in
BMP1 Causes Secretion and Glycosylation
Defects In Vitro and Loss of Protease Activity
In Vivo
(A) Immunoblot of HEK 293T cells transfected
with either Flag-tagged WT BMP1 (BMP1-Flag;
lanes 1 and 4) or p.Gly12Arg-substituted BMP1
(BMP1mut-Flag; lanes 2 and 5) and untransfected
control cells (control; lanes 3 and 6). Immuno-
blotting shows that the p.Gly12Arg protein (lanes
1–3) isolated from cell lysates had increased
mobility; reduced amounts of this BMP1 protein
were secreted into the medium (lanes 4–6).
(B) Immunoblot of lysates of HEK 293T cells
transfected with either Flag-tagged WT BMP1
(BMP1-Flag; lanes 1 and 2) or p.Gly12Arg-
substituted BMP1 (BMP1mut-Flag; lanes 3 and 4)
and untransfected controls (control; lanes 5 and
6). After being harvested, lysates were either
treated with N-glycosidase (lanes 2, 4, and 6) or
left untreated (lanes 1, 3, and 5). The predomi-
nant mutant-BMP1 band with increased mobility
migrates at the same rate as deglycosylated WT
BMP1.
(C–I) The p.Gly12Arg-substituted BMP1 exhibits
reduced Chordinase activity in vivo. Lateral views
of uninjected 24 hpf zebrafish embryos (C) and
embryos injected with RNA encoding either
WT BMP1 (BMP1; D and G) or p.Gly12Arg
signal-peptide variant BMP1 (BMP1mut; E and H).
Chordinase activity was assessed by its ability to
ventralize WT embryos (C–E) or rescue dorsalized
(chordin RNA injected) embryos (F–H). In both
assays, the mutant BMP1 showed reduced ability
to counteract either the endogenous or exoge-
nous Chordin (quantified in I).A second zebrafish fin mutant, microwaved (med),
displays a phenotype similar to that of frf mutants—de-
layed ossification at 11 dpf (Figures 4G and 4H) and undu-
lation of the larval fin (Figures S1I and S1J).25 As with frf
mutants, all vertebrae of med mutants eventually ossify
(Figures S1A–S1D). To compare the two mutants in more
detail, we quantified bone density in the adults by mi-
croCT analysis (Figures 5A–5D) and assessed both vertebral
and lepidotrichial bone. Both frf andmed distal fin rays had
reduced bone density when they were compared to their
respective siblings, but the bone of the vertebrae had diver-
gent phenotypes. Like the lepidotrichial bone, the verte-
brae of med mutants also had reduced bone density;
surprisingly, however, frf-mutant adult vertebrae had
increased bone density (Figure 5E) similar to that seen in
the human individuals with the BMP1 mutation, whereas
med mutants displayed traits similar to those seen in indi-
viduals with classical OI. Meiotic mapping revealed close
linkage between the med locus and zebrafish col1a1a on
linkage group 3 (data not shown). Sequencing of col1a1a
cDNA (GenBank accession number BC063249.1) from
med/ mutants identified a G>A transition predicted to
substitute a highly conserved glutamic acid with a lysineThe Amat position 888 (p.Glu888Lys; Figures S1K–S1N). Thus,
the microwaved mutant constitutes a zebrafish model of
classical OI.
The Zebrafish frilly fins Mutant is Caused by a bmp1
Mutation
We next mapped the frf mutant to an interval that con-
tains bmp1a on linkage group 8 (Figure S2A). Sequencing
of the bmp1a cDNA (GenBank accession number
BC163535.1) from five frf alleles identified two missense
mutations causing the substitutions p.Ile124Asn and
p.Val223Asp (Figure 2D and Figures S2F and S2H), which
are within the protease domain and which affect con-
served amino acids (Figures S2K and S2L); a nonsense
mutation that truncates the protein at the end of
the proteolytic domain (p.Tyr306*; Figure 2D and Fig-
ure S2G); and two splice-site mutations, one (associated
with frf tm317) leading to the deletion of 21 amino acids
from the proteolytic domain (p.Gln290_Arg310del; Fig-
ure 2D and Figures S2B, S2C, and S2I) and another (associ-
ated with frf tf5) generating four main erroneous splicing
products (p.Tyr378Serfs*6, p.Lys390Serfs*6, p.Gly395ins-
GlyLeuArg*, and p.Lys394_Gly395ins8; Figure 2D anderican Journal of Human Genetics 90, 661–674, April 6, 2012 667
Figure 4. The Zebrafish frilly finsMutant Displays Larval Fin-Fold
Ruffling and Osteogenesis Defects
(A and B) Ventral view of the posterior medial fin fold at 3 dpf in
a frilly fins (frf) (B) larva showing undulations in the fin fold, which
normally has a linear morphology (A).
(C and D) Compared to the siblings, 4-month-old frf / adults (D)
are short and display axis defects, body curvature, and fin and
craniofacial dysmorphogenesis.
(E–L) Alizarin-red staining of frf / (F, J, and L),microwaved (med/)
(H), andWTsiblings (E, G, I, and K) at 11 dpf (E–H), 15 dpf (I and J),
and 4 months (K and L). Both frf andmed display reduced ossifica-
tion of the vertebrae (F and H), whereas nascent vertebrae are
osteopenic and dysmorphic (J). Tail fins in frf / have lost the
WT fan shape (K) and display fracture calluses, reduced bifurca-
tions (L), and crinkled lepidotrichia, which often fuse to each
other (L; inset).Figures S2D, S2E, and S2J). We were able to rescue the frf
larval fin phenotype by injecting a DNA construct driving
zebrafish Bmp1a expression from a heat-shock promoter,
further supporting the conclusion that frilly fins represents
a bmp1a mutant (Figures S3A–S3C).
Bmp1 Function in Bone Formation and Development
To understand the function of Bmp1 in bone formation,
we characterized zebrafish bmp1a gene expression and
the frf mutant phenotype in more detail. Zebrafish
bmp1a is expressed in osteoblasts. During larval stages,
we observed strong expression in fin mesenchyme cells
within the fin fold at a stage contemporaneous with the
appearance of the fin-fold defect in frf mutants (Figures
6A and 6B). In addition, we noted expression in the floor
plate and hypochord, branchial arches and operculum668 The American Journal of Human Genetics 90, 661–674, April 6, 2(Figures 6A and 6C), and sites of bone formation in the
head. We confirmed expression of bmp1a in osteoblasts
by double-fluorescent in situ hybridization with the zebra-
fish osteoblast maker col10a1. We found consistent overlap
of both mRNAs in osteoblasts on the operculum and
cleithrum (Figures 6E and 6E00; data not shown). We also
noted expression in clusters of cells arranged metameri-
cally adjacent to the notochord, a location and arrange-
ment consistent with osteoblasts of the vertebral column
(Figure 6D).
To determine whether the compromised ossification in
frilly fins mutant larvae is due to insufficient generation
of osteoblasts, we analyzed expression of sp7, osteopontin,
and collagen10a1 by in situ hybridization in frf mutants.
Osteoblasts were found to be normal in number and
location, consistent with the interpretation that loss of
bmp1a does not disrupt osteoblast generation, number,
localization, or differentiation (Figures 6F–6K). We con-
firmed the presence of normal osteoblast numbers by first
crossing frf into the sp7:mcherry transgenic line,26 which
labels osteoblasts on skeletal structures. Compared to WT
cells, mCherry-positive cells did not decrease in number
in the frfmutant vertebrae or fins, even at the earliest times
that such cells are visible (Figures 6L and 6Mand Figure S4A
and S4B). We obtained a similar result by immunostaining
with the osteoblast-specific zns5 antibody, although we did
observe altered cellular morphology—osteoblasts appeared
more cuboidal in the mutant than did the flattened cells in
the WT bone (Figures 7A–7D). The latter effect was also
seen in the lepidotrichia when imaged by transmission
electron microscopy (Figures 7E and 7F). However, no
significant change in osteoblast number was observed
in fin rays (Figure S4C). To test whether this altered-
morphology phenotype is concomitant with a loss of oste-
oblast activity, we exposed frf mutants to RA, which was
previously described as stimulating osteoblast activity
and causing precocious hyperossification of the entire
vertebral column.26,33 Unlike in WT (Figures 7G and 7H),
ossification in frf mutants was almost completely refrac-
tory to RA treatment (Figures 7I and 7J), consistent with
a defect in the ability of osteoblasts to effectively generate
osteoid, downstream of osteoblast differentiation and
activity.
Bmp1 could potentially affect the ossification process
through proteolytic cleavage processes involving a number
of targets. Among these, its ability to cleave and inactivate
the BMP2/4 inhibitor Chordin is well documented and has
the potential to affect the ossification process.38,39 To test
whether the frf phenotypes could be due to an excess of
uncleaved Chordin, we generated frf/ chordin/
double-mutant adults (in which the early ventralized
phenotype was rescued by chordin mRNA injection). As
previously described,40 Chordin function is dispensable
after gastrulation for axial skeleton generation and
patterning (Figures S5A and S5C), yet it remains possible
that elevated levels might perturb osteogenesis. However,
Chordin loss at late larval stages failed to rescue the frf012
Figure 5. CT Analysis of frilly fins and microwaved Bone Reveals Altered Adult Bone Densities
(A–D) microCT analysis of bone density in a 7-month-old frf/ mutant (B) and its WT sibling (A) as well as amed/ mutant (D) and its
WT sibling (C). Note that although themedmutant looks overtly normal (D), the frfmutant skeleton displays axial curvature and defects
in the head skeleton (B).
(E) Box plots of density measurements derived from microCT analysis of mutants and sibling vertebrae and fin lepidotrichia. med
mutants have osteopenia of both lepidotrichia in the fins and vertebrae (blue boxes). Although frf mutants also display osteopenia of
the fins, they show an increased bone density in the vertebrae (green boxes). The Mann-Whitney U test was performed for comparing
densities between mutants and siblings for each bone type (*** denotes p < 0.001; ** denotes p < 0.01; and n ¼ 8 for all data sets). Boxes
indicate the median and the 25th and 75th percentiles, whereas the whiskers display the largest and smallest values.defect (Figures S5B and S5D). In addition to Chordin
cleavage, Bmp1 also plays a role in generating mature
Collagen I through the cleavage of the C-terminal propep-
tide domain (Figure 8A). Indeed, the inability of RA toFigure 6. bmp1a Is Expressed in Osteoblasts, which Appear Norm
(A–D) In situ hybridization of bmp1a at 4 dpf (A), 2 dpf (B), 3 dpf (C
fin fold (A and B), floor plate and hypochord (A, open and filled arrow
(C, arrowhead) and perichordal cells of the anterior notochord (D, a
(E–E00) Confocal images of double-fluorescent in situ hybridizations s
marker collagen10a1 (E0 and E00; green) in osteoblasts on the operculum
by arrowheads), and central, more mature osteoblasts express slightl
(F–K) Perichordal expression of osteoblast markers is not disrupted
(F, H, and J) and frf/ (G, I, and K) larvae hybridized with probes fo
(L and M) Confocal images of sp7:mCherry-expressing osteoblasts on
reduction in osteoblast numbers in the mutant.
The Amrescue the ossification process in frf mutants and the simi-
larity between the frf and med vertebrae phenotypes
suggest that the major requirement for Bmp1 in bone
formation is the generation of mature Collagen I. Usingally Differentiated in frilly fins
) and 8 dpf (D). Expression is seen in fin mesenchyme cells of the
heads, respectively), branchial arches (C, asterisk), and operculum
rrowheads).
howing coexpression of bmp1a (E and E00; red) and the osteoblast
at 4 dpf. Most cells express both markers (three cases highlighted
y higher levels of col10a1.
in frf mutants. Lateral images of anterior notochord of 8 dpf WT
r sp7 (F and G), osteopontin (H and I), and collagen10a1 (J and K).
vertebrae of WT (L) and frfmutant (M) larvae at 20 dpf. There is no
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Figure 7. Osteoblasts in frilly fins Mutants Have Altered Morphology but Cannot Hyperossify upon RA Treatment
(A–D) Immunohistochemical (A and B) and immunofluorescent (C and D) staining of osteoblasts with the zns5 antibody (brown stain
in A and B; green stain in C and D) in WT (A and C) and frf/ (B and D) fins at 120 dpf. (A) and (B) display lateral views of fin rays
counterstained with alizarin red (bone is in red), whereas (C) and (D) are transverse sections of fin rays counterstained with DAPI
(blue). There is no loss in number of zns5þ osteoblasts in frf/ mutants. However, the osteoblasts display an altered morphology
when viewed in cross section; they appear more cuboidal where they are normally flat cells that maintain intimate contact with the
bone surface (arrowheads in C and D).
(E and F) Electron micrographs of transverse sections of adult fin rays. Osteoblasts are indicated with red arrowheads and appear flat in
WT fins (E) yet more cuboidal in frf/ fins (F).
(G–J) Alizarin-red staining of 11 dpfWT (G and H) and frf/ larvae (I and J) treated with (H and J) or without (G and I) RA for enhancing
osteoblast activity. Despite normal numbers of differentiated osteoblasts in frf mutants, these cells are unable to mineralize the
notochord efficiently upon RA stimulation; this suggests a defect downstream of osteoblast differentiation.the picrosirius-red staining method to enhance birefrin-
gency of highly ordered fibrillar collagen,35 we analyzed
collagen fibrillogenesis. At all stages analyzed and in both
fins and vertebrae, we found a significant reduction in
birefringence in frf/ mutants; this indicates a loss of
fibrillar-collagen structure (Figures 8B–8G). Ultrastructural
imaging of fibrillar collagen in the fins at 6 dpf by transmis-
sion electron microscopy revealed disruption to the
normal periodic collagen fibril (Figure 8H) in the mutant
(Figure 8I). Immunoblot analysis, employing an antibody
raised against zebrafish Col1a1a, demonstrated compro-
mised C-propeptide removal in frf/ mutants at both
larval and adult stages (Figures 8J and 8K).
Because the frf larval fin phenotype is most likely due to
loss of Bmp1-mediated collagen processing, we used a test
for such processing as an in vivo assay to assess the activity
of BMP1 with the p.Gly12Arg substitution. Toward this
end, we injected into frf embryos DNA constructs contain-
ing a heat-shock promoter upstream of either human WT
BMP1 coding sequences or a mutant version bearing the
p.Gly12Arg substitution. This assay demonstrated that
BMP1 with the p.Gly12Arg substitution had a significantly
reduced ability to rescue the fin defect (Figures S3A–S3E);
this finding suggests that p.Gly12Arg causes a reduced
ability to augment in vivo the deficit in frf C-propeptidase
activity.670 The American Journal of Human Genetics 90, 661–674, April 6, 2Discussion
In this study, we identify a homozygous missense muta-
tion substituting an amino acid in the signal peptide of
BMP1 in a Turkish consanguineous family with auto-
somal-recessive high-bone-density OI. BMP1 is known to
have several functions in different pathways, including
the proteolytic processing of the procollagen I C-propep-
tide for the generation of mature collagen type I. On the
basis of this information and given the fact that the
majority of OI cases are associated with defects in COL1A
genes or in genes involved in collagen I biosynthesis,3,5
we propose BMP1 as a highly relevant gene in this
OI-disease context.
The identified substitution, p.Gly12Arg, is located in
exon 1, which encodes the signal peptide of BMP1.
Although it remains to be determined whether the sig-
nal-peptide variant results in a reduction of BMP1 enzy-
matic activity per se, bioinformatic analysis predicted a
disruption of the signal peptide and therefore suggested a
failure of intracellular protein sorting of premature BMP1
and an exclusion from the secretory pathway. Subse-
quently, we confirmed in in vitro assays that the amino
acid substitution leads to severely reduced post-transla-
tional N-glycosylation of the mutant protein and impaired
protein secretion (Figures 3A and 3B). Our results agree012
Figure 8. frf Displays Defects in Fibrillar Collagen Order and Col1a1a Processing
(A) Major proteolytic roles of Bmp1 include removing the C-propeptide (orange ovals) of pro-Collagen I and cleaving the BMP2/4 inhib-
itor, Chordin (red hexagon), to release free BMP2/4 (green oval).
(B–G) Picrosirius-red stained sagittal (B–E) and transverse (F and G) sections of WT (B, D, and F) and frf/ (C, E, and G) larvae at 11 dpf
(B and C), 20 dpf (D and E), and 4 months (F and G). Sections viewed under polarized light reveal the reduced collagen-fiber-associated
birefringency in the Centra region (B–E) and fin rays (F and G) in frf/ mutant (C, E, and G) and WT (B, D, and F) larvae.
(H and I) Transmission electron micrographs of longitudinal sections of WT (H) and frf/ (I) larval medial fins at 6 dpf show loss of
structured collagen fibers in the mutant.
(J and K) Immunoblots of protein extracted fromWT (lane 1) and frf/mutant (lane 2) larvae probed with an antibody directed against
zebrafish Collagen1a1a (upper panels in both J and K) or an antibody against b-actin as a loading control (lower panels). The four
possible Collagen1a1 forms are indicated on the right; these forms include Procollagen1a1 retaining both C- and N- terminal propetides
(Pro a1[I]), mature collagen a1(I) retaining neither propeptide (a1[I]), a form retaining only the N-propeptide (pN a1[I]), and a form
retaining only the C-propeptide (pC a1[I]). In 6 dpf (J) and 4-month-old (K) frf/ mutants, the two forms retaining the C-propeptide
predominate.with those published in a previous study (Garrigue-Antar
et al.37), which showed the importance of N-glycosylation
for secretion and stability of BMP1. Compromised BMP1
secretion thus reduces the availability of BMP1 in the
extracellular matrix, potentially leading to the insufficient
processing of substrates, including the procollagen I C-pro-
peptide. Indeed, we were able to demonstrate measurably
reduced processing of two substrates by p.Gly12Arg-
substituted BMP1 in two in vivo assays in zebrafish. Exog-
enous Bmp1 has been described as cleaving the dorsal
determinant, Chordin, and leading to ventralization of
zebrafish embryos.41 We exploited this finding to show
that the p.Gly12Arg-substituted version of BMP1 was less
efficient at ventralizing the embryo than the WT BMP1
(Figure 3). In addition, unlike the WT BMP1, the
p.Gly12Arg-substituted BMP1 was unable to measurably
rescue the larval fin ruffling of the bmp1a zebrafish mutant
(Figure S3); larval fin ruffling is associated with defective
collagen-rod formation. Thus, we have shown that
p.Gly12Arg leads to both reduced secretion and subse-
quent reduced processing of the substrates Chordin and
Collagen I.
Such reduced C-propeptide cleavage predicts the
assembly of procollagen instead of mature collagen into
collagen I fibrils. Immunoblot analysis of both larval andThe Amadult zebrafish protein samples demonstrated that forms
retaining the C-propeptide predominate upon reduction
of Bmp1 function (Figure 8). Unfortunately, no material
was available to show this effect in the affected individuals.
We hypothesize that this results in an impairment of the
collagen matrix within the bone structure and could be
the major cause in the underlying pathomechanism.
Supporting this hypothesis, use of the birefringent
collagen stain, picrosirius red, demonstrated less ordered
collagen-fiber structure in zebrafish bmp1a mutants (Fig-
ure 8). Interestingly, recent studies have assumed that
collagen C-propeptides assembled within collagen fibrils
would either increase the intrafibrillar spacing or directly
serve as nucleators of mineralization.15 This might explain
the high bone mineral density we noted in our individuals
(Figure 1 and Table 1). Our findings provide evidence that
insufficient collagen processing caused by p.Gly12Arg
most likely leads to ectopic accumulation of minerals in
the bone. However, this bone is nonetheless structurally
compromised, leading to fragility. The precise pathophysi-
ology of increased bone mineralization upon defective
collagen processing remains unclear and needs to be inves-
tigated further.
We note similar defects in bone formation in the zebra-
fish frilly fins mutant, and we show that these defectserican Journal of Human Genetics 90, 661–674, April 6, 2012 671
correspond to mutations in bmp1a. Alizarin-red staining
demonstrated delayed ossification at larval stages and mal-
formation of adult skeletal structures with evidence of
fractures (Figure 4). Quantification of mineral content by
microCT analysis demonstrated a higher mineral content
of mature bone, as seen in the individuals. The reason for
the divergent mineral-content phenotypes between the
larval-stage frilly fins mutant and the adult-stage mutant
is currently unclear. We hypothesize that there is a differ-
ence in mineralization rate between the two stages and
that mature collagen is rate limiting during the initial
deposition in larval stages, whereas in adult stages, the
retained telopeptide gradually induces increased minerali-
zation through a mechanism that has not been deter-
mined. Accordingly, the only location found to have
reduced mineralization in adult frilly fins is the distal fin,
a site of bone deposition.
As the first described animal model with reduced
Bmp1 function in an adult, frilly fins was used for the
investigation of the role of this protease in bone forma-
tion. We showed that although generation and patterning
of osteoblasts is unaffected (Figure 6), there was an
intriguing alteration in morphology of the osteoblasts—
they adopted a cuboidal shape (Figure 7). Although this
might indicate a defect in the osteoblasts themselves, we
favor the interpretation that this is a result of reduced
adhesion to the compromised bone matrix. Supporting
this is the in vitro observation that osteoblasts cultured
on bone matrix lacking collagen appeared rounded com-
pared to flattened cells cultured on a purified mineralized
collagen matrix.42
The role of Bmp1 (and other Tolloid-related proteins) in
dorsal-ventral patterning through Chordin cleavage is
well documented. We could, however, conclusively
show that this was not the relevant substrate underlying
the frilly fins bone phenotype (Figure S5). In fact, multiple
lines of evidence from our analysis support the interpreta-
tion that the major role of Bmp1 in ossification is
removal of the C-propeptide from Collagen I. First, we
note similarity of frf to the microwaved mutant, which
we identified as a collagen1a1a mutant (Figure 4). Second,
frf larvae are not able to hyperossify the vertebral column
upon retinoic-acid stimulation of the osteoblasts (Fig-
ure 7), most consistent with a defect that is considerably
downstream in the process of osteoid formation. Finally,
we show compromised Collagen-I processing and
higher-order structure in frf biochemically and histologi-
cally (Figure 8).
While we were preparing this manuscript, Martinez-Glez
et al.43 described a homozygous missense mutation
causing an alteration in the protease domain of BMP1 in
two affected individuals from an Egyptian family affected
by severe autosomal-recessive OI. In line with our findings,
concomitant abnormal procollagen I C-propeptide pro-
cessing was described. Comparison of the individuals’
phenotypes in both studies showed the following differ-
ences: affected individuals in the Egyptian family pre-672 The American Journal of Human Genetics 90, 661–674, April 6, 2sented with classical autosomal-recessive OI, whereas our
individuals, as well as the zebrafish model, presented
with bone fragility associated with an increase in bone
mineral density. Interestingly, Lindahl K. et al.15 very
recently described COL1A1 mutations affecting the BMP1
C-propeptide cleavage site; also, the individuals in this
study presented with an increased-mineralization OI
phenotype very similar to our individuals, suggesting
that impaired BMP1-related collagen C-propeptide cleav-
age (either by mutations in BMP1 or mutations affecting
the BMP1 cleavage site in COL1A1) causes a distinct
form of OI. In contrast, the missense mutation described
by Martinez-Glez et al.43 might have different functional
consequences and thereby cause phenotypic variability
and differences in the severity of the disease.
All together, our combined data in humans and
zebrafish define the molecular and cellular bases of
BMP1-dependent osteogenesis and show the importance
of this protein for bone formation and stability. These
data, in both humans and zebrafish, support the finding
that deficits in removal of the C-propeptide from Collagen
I result in autosomal-recessive OI with high bone mineral
density.15Supplemental Data
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